Discover
OSCR
Oscar Health, Inc.
31.90
200 x undefined
300 x undefined
bid
ask
+
3.38
11.85%
250 @ 04:00 PM
31.82 -0.08 (0.25%)
| Ytd | 121.99% | |
| 1y | 55.99% |
28.91
day range
32.05
10.69
52 week range
32.06
| Open | 28.70 | Prev Close | 28.52 | Low | 28.91 | High | 32.05 | Mkt Cap | 9.62B |
| Vol | 6.12M | Avg Vol | 7.54M | EPS | -0.54 | P/E | N/A | Forward P/E | 21.48 |
| Beta | 2.39 | Short Ratio | 2.21 | Inst. Own | 67.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 23.59 | 200-d Avg | 17.77 | 1yr Est | 22.60 |
| Income Statement | |||
| Total Revenue | 4.65B | ||
| Revenues (USD) | 4.65B | ||
| Cost of Revenue | 3.23B | ||
| Gross Profit | 1.42B | ||
| Operating Expenses | 713.25M | ||
| Selling, General and Administrative Expense | 706.23M | ||
| Operating Income | 704.09M | ||
| Interest Expense | 5.38M | ||
| Income Tax Expense | 19.75M | ||
| Net Income | 679.00M | ||
| Net Income Common Stock | 679.00M | ||
| Net Income Common Stock (USD) | 679.00M | ||
| Consolidated Income | 679.02M | ||
| Net Income to Non-Controlling Interests | 27.00K | ||
| Earnings per Basic Share | 2.28 | ||
| Earnings per Basic Share (USD) | 2.28 | ||
| Earnings per Diluted Share | 2.07 | ||
| Earning Before Interest & Taxes (EBIT) | 704.13M | ||
| Earning Before Interest & Taxes (USD) | 704.13M | ||
| Weighted Average Shares | 298.18M | ||
| Weighted Average Shares Diluted | 329.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.81B | ||
| Cash and Equivalents (USD) | 4.81B | ||
| Investments | 3.29B | ||
| Investments Current | 1.99B | ||
| Investments Non-Current | 1.30B | ||
| Trade and Non-Trade Receivables | 951.71M | ||
| Current Assets | 7.78B | ||
| Property, Plant & Equipment Net | 94.19M | ||
| Total Assets | 9.29B | ||
| Total Debt | 430.88M | ||
| Current Liabilities | 7.14B | ||
| Debt Non-Current | 430.88M | ||
| Total Liabilities | 7.62B | ||
| Accumulated Retained Earnings (Deficit) | -2.62B | ||
| Accumulated Other Comprehensive Income | 5.00M | ||
| Shareholders Equity | 1.66B | ||
| Shareholders Equity (USD) | 1.66B | ||
| Assets Non-Current | 1.51B | ||
| Total Debt (USD) | 430.88M | ||
| Deferred Revenue | 172.00M | ||
| Liabilities Non-Current | 482.24M | ||
| Trade and Non-Trade Payables | 6.97B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.02M | ||
| Net Cash Flow from Financing | -3.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.03B | ||
| Capital Expenditure | -8.79M | ||
| Issuance (Purchase) of Equity Shares | 1.14M | ||
| Issuance (Repayment) of Debt Securities | -4.74M | ||
| Net Cash Flow from Investing | -590.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -581.46M | ||
| Net Cash Flow from Operations | 2.62B | ||
| Share Based Compensation | 15.97M | ||